RecruitingACTRN12606000378527

The role of spirometry (lung function testing) in the management of chronic respiratory diseases (asthma and COPD) in general practice to improve quality of life.

The role of spirometry in managing chronic respiratory diseases in general practice to improve quality of life.


Sponsor

Monash UniversityDepartment of Epidemiology & Preventive Medicine

Enrollment

726 participants

Start Date

Mar 21, 2006

Study Type

Interventional

Conditions

Summary

The study has been designed around the research questions a) do patients with chronic respiratory disease (asthma and/or COPD) managed with lung function testing (spirometry) through general practice have better health outcomes than patients managed without spirometry? and b) to what degree does the use of spirometry influence the way general practitioners manage patients with chronic respiratory disease? This study aims to trial lung function testing ( spirometry) as an intervention for management of asthma and chronic obstructive pulmonary disease ( COPD) in a General practice setting. The main objectives are a) to evaluate the impact of spirometry on health outcomes of patients with asthma and COPD,compared with usual care alone ( no spirometry) and b) to identify the barriers and enablers to spirometry in general practice and primary care.


Eligibility

Sex: Both males and femalesMin Age: 7 YearssMax Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at whether using a breathing test called spirometry (lung function testing) helps doctors and patients better manage asthma and chronic obstructive pulmonary disease (COPD) in a general practice (GP) setting. Spirometry measures how well air moves in and out of the lungs. Some GPs currently manage these conditions without regular lung function tests. Researchers want to find out if patients whose GPs use spirometry regularly have better health outcomes — such as fewer symptoms, less hospitalisation, and better quality of life — compared to patients whose GPs use usual care alone. You may be eligible if: - You are between 7 and 70 years old - You have been diagnosed with asthma or COPD by a doctor - You attend a participating general practice in Melbourne or surrounding regions - You can understand English and give written consent You may NOT be eligible if: - You cannot be reached by phone - You are already participating in another asthma or COPD research study - You have only mild, infrequent asthma (episodic) - You have a complex medical condition such as severe mental illness or cancer Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

This study is a Double Blind Randomised Controlled Trial ( RCT) where practices are randomly allocated to: - Group 1 ( intervention with spirometry) For 12 months practices will receive full spiromet

This study is a Double Blind Randomised Controlled Trial ( RCT) where practices are randomly allocated to: - Group 1 ( intervention with spirometry) For 12 months practices will receive full spirometry intervention and an interpretation of results will be notified to the treating GP -Group 2 (intervention without spirometry) For 12 months practices will receive spirometry before and after the trial, but no results will be reported to the GP


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000378527